Vivanza Biosciences Limited has announced the resignation of Mr. Hemant Amrish Parikh as Non-Executive Director, effective March 17, 2026. The company informed BSE Limited about this board change in compliance with regulatory disclosure requirements under SEBI Listing Obligations and Disclosure Requirements Regulations, 2015.

Director Resignation Details

Mr. Hemant Amrish Parikh, holding Director Identification Number 00027820, submitted his resignation letter on March 17, 2026, citing personal reasons for his departure. The resignation became effective from the close of business hours on the same date.

Regulatory Compliance and Documentation

The company has fulfilled its disclosure obligations under Regulation 30 of SEBI Listing Regulations, referencing SEBI Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026, last amended on January 30, 2026. As part of the regulatory filing, Vivanza Biosciences provided comprehensive details about the directorial change to BSE Limited, including the reason for cessation and effective date.

The resignation letter was signed by Mr. Parikh from his residence at B-1, 1st Floor, Opp. Gurudwara, Bodakdev, Ahmedabad - 380054. He specifically requested the company to acknowledge receipt and submit necessary forms with the Registrar of Companies for immediate relief from his directorial duties.

Material Reasons Confirmation

Importantly, Mr. Hemant Amrish Parikh confirmed to the company that there are no material reasons for his resignation other than the personal reasons mentioned in his resignation letter dated March 17, 2026. This confirmation was included as part of the regulatory disclosure to ensure transparency with stakeholders.

The announcement was digitally signed by Managing Director Jayendra Amichand Mehta (DIN: 08210602) on March 17, 2026, at 14:18:21 +05'30' on behalf of Vivanza Biosciences Limited. The company's registered office is located at 403, Sarthik 2, Opp. Rajpath Club, S. G. Highway, Ahmedabad 380054, and it operates under CIN: L24105GJ1982PLC005057.

Vivanza Biosciences Limited has officially notified BSE Limited about the approved amendment to its Memorandum of Association (MOA) for business expansion into plastic polymer films and packaging materials manufacturing. The company submitted the formal intimation on December 18, 2025, under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Regulatory Notification Details

Managing Director Jayendra Mehta (DIN: 08210602) formally communicated the MOA alteration to BSE, confirming that shareholders have approved the insertion of a new sub-clause 7 after the existing sub-clause 6 of Clause III(A). The notification follows the company's successful postal ballot results announced on December 17, 2025:

Comprehensive Business Scope

The approved MOA amendment provides detailed specifications for the company's new business activities. The expanded scope includes manufacturing plastic polymer films of 25 microns thickness, plastic bags and sacks made from polyethylene (PE) and polypropylene (PP), and paper bags for packaging with or without plastic coating or lamination:

Regulatory Compliance Framework

The amendment is subject to necessary approvals from the Ministry of Corporate Affairs, Stock Exchanges, and other regulatory authorities as applicable. The company has outlined comprehensive operational capabilities including procurement and import of raw materials, research and development activities, and obtaining necessary patents, licenses, and regulatory approvals.

Strategic Transformation

The formal notification confirms Vivanza Biosciences' strategic shift from a pure biosciences operation to a diversified manufacturing entity. The 99.90% shareholder approval demonstrates exceptional investor confidence in the company's expansion strategy into the growing packaging industry, potentially opening significant new revenue streams across multiple industrial and consumer applications.

Implementation Timeline

With the postal ballot process completed and regulatory notification submitted, the company can now proceed with implementing its diversification plans. The voting process, conducted by scrutinizer CS Chintan K. Patel and managed through Purva Sharegistry (India) Private Limited's e-voting platform, ensures full compliance with Section 110 of the Companies Act, 2013.